Genentech’s Investigational Immunotherapy MPDL3280A Doubled the Likelihood of Survival Compared with Chemotherapy in People with a Specific Type of Lung Cancer

… previously treated, advanced non-small cell lung cancer did on MPDL3280A -- Genentech … of Breakthrough Therapy Designation in lung cancer. Genentech currently has three Phase … advanced stages. About Genentech in Lung Cancer Lung cancer is a major area of …